Brokers REVEAL New Rating and Price Target For Solta Medical

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on July 5th.

Solta Medical (NASDAQ:SLTM): Ascendiant Capital Markets initiated coverage of this company with a rating of Buy and a price target of $3.5.

Don’t Miss: Here’s Why Apple is SMILING After the Fireworks.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business